Table of Contents Author Guidelines Submit a Manuscript
Journal of Nanomaterials
Volume 2011 (2011), Article ID 308016, 10 pages
http://dx.doi.org/10.1155/2011/308016
Research Article

Optimization of the Preparation Process for an Oral Phytantriol-Based Amphotericin B Cubosomes

1School of Pharmaceutical Sciences, Sun Yat-Sen University, Guangzhou 51006, China
2Department of Pharmaceutical Sciences, Gannan Medical College, Ganzhou, China
3GuangDong Medical College, Dongguan, China
4Anton-Paar, Shanghai, China
5GuangDong Research Center for Drug Delivery Systems, Guangzhou, China

Received 25 April 2011; Revised 25 June 2011; Accepted 26 June 2011

Academic Editor: Xing J. Liang

Copyright © 2011 Zhiwen Yang et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. L. Ostrosky-Zeichner, K. A. Marr, J. H. Rex, and S. H. Cohen, “Amphotericin B: time for a new “gold standard”,” Clinical Infectious Diseases, vol. 37, no. 3, pp. 415–425, 2003. View at Publisher · View at Google Scholar · View at Scopus
  2. J. S. Dangi, S. P. Vyas, and V. K. Dixit, “Effect of various lipid-bile salt mixed micelles on the intestinal absorption of amphotericin-B in rat,” Drug Development and Industrial Pharmacy, vol. 24, no. 7, pp. 631–635, 1998. View at Google Scholar · View at Scopus
  3. M. L. Littman, P. L. Horowitz, and J. G. Swadey, “Coccidioidomycosis and its treatment with amphotericin B,” The American Journal of Medicine, vol. 24, no. 4, pp. 568–592, 1958. View at Google Scholar · View at Scopus
  4. H. M. Kravetz, V. T. Andriole, M. A. Huber, and J. P. Utz, “Oral administration of solubilized amphotericin B,” The New England Journal of Medicine, vol. 265, pp. 183–184, 1961. View at Google Scholar · View at Scopus
  5. D. B. Louria, “Some aspects of the absorption, distribution, and excretion of amphotericin B in man,” Antibiotic Medicine & Clinical Therapy, vol. 5, no. 5, pp. 295–301, 1958. View at Google Scholar · View at Scopus
  6. O. Kayser, C. Olbrich, V. Yardley, A. F. Kiderlen, and S. L. Croft, “Formulation of amphotericin B as nanosuspension for oral administration,” International Journal of Pharmaceutics, vol. 254, no. 1, pp. 73–75, 2003. View at Publisher · View at Google Scholar · View at Scopus
  7. G. Delmas, S. Park, Z. W. Chen et al., “Efficacy of orally delivered cochleates containing amphotericin B in a murine model of aspergillosis,” Antimicrobial Agents and Chemotherapy, vol. 46, no. 8, pp. 2704–2707, 2002. View at Publisher · View at Google Scholar · View at Scopus
  8. B. Amarji, Ajazuddin, D. Raghuwanshi, S. P. Vyas, and P. Kanaujia, “Lipid nano spheres (LNSs) for enhanced oral bioavailability of amphotericin B: development and characterization,” Journal of Biomedical Nanotechnology, vol. 3, no. 3, pp. 264–269, 2007. View at Publisher · View at Google Scholar
  9. M. L. Lynch, A. Ofori-Boateng, A. Hippe, K. Kochvar, and P. T. Spicer, “Enhanced loading of water-soluble actives into bicontinuous cubic phase liquid crystals using cationic surfactants,” Journal of Colloid and Interface Science, vol. 260, no. 2, pp. 404–413, 2003. View at Publisher · View at Google Scholar · View at Scopus
  10. X. Peng, X. Wen, X. Pan, R. Wang, B. Chen, and C. Wu, “Design and in vitro evaluation of capsaicin transdermal controlled release cubic phase gels,” The American Association of Pharmaceutical Scientists Tech, vol. 11, no. 3, pp. 1405–1410, 2010. View at Publisher · View at Google Scholar · View at Scopus
  11. C. M. Chang and R. Bodmeier, “Swelling of and drug release from monoglyceride-based drug delivery systems,” Journal of Pharmaceutical Sciences, vol. 86, no. 6, pp. 747–752, 1997. View at Publisher · View at Google Scholar · View at Scopus
  12. C. M. Chang and R. Bodmeier, “Effect of dissolution media and additives on the drug release from cubic phase delivery systems,” Journal of Controlled Release, vol. 46, no. 3, pp. 215–222, 1997. View at Publisher · View at Google Scholar · View at Scopus
  13. B. Siekmann, H. Bunjes, M. H. J. Koch, and K. Westesen, “Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases,” International Journal of Pharmaceutics, vol. 244, no. 1-2, pp. 33–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  14. H. Chung, J. Kim, J. Y. Um, I. C. Kwon, and S. Y. Jeong, “Self-assembled “nanocubicle” as a carrier for peroral insulin delivery,” Diabetologia, vol. 45, no. 3, pp. 448–451, 2002. View at Publisher · View at Google Scholar · View at Scopus
  15. J. Bender, M. B. Ericson, N. Merclin et al., “Lipid cubic phases for improved topical drug delivery in photodynamic therapy,” Journal of Controlled Release, vol. 106, no. 3, pp. 350–360, 2005. View at Publisher · View at Google Scholar · View at Scopus
  16. L. B. Lopes, J. L. C. Lopes, D. C. R. Oliveira et al., “Liquid crystalline phases of monoolein and water for topical delivery of cyclosporin A: characterization and study of in vitro and in vivo delivery,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 63, no. 2, pp. 146–155, 2006. View at Publisher · View at Google Scholar · View at Scopus
  17. B. J. Boyd, D. V. Whittaker, S. M. Khoo, and G. Davey, “Lyotropic liquid crystalline phases formed from glycerate surfactants as sustained release drug delivery systems,” International Journal of Pharmaceutics, vol. 309, no. 1-2, pp. 218–226, 2006. View at Publisher · View at Google Scholar · View at Scopus
  18. Y. D. Dong, I. Larson, T. Hanley, and B. J. Boyd, “Bulk and dispersed aqueous phase behavior of phytantriol: effect of vitamin E acetate and F127 polymer on liquid crystal nanostructure,” Langmuir, vol. 22, no. 23, pp. 9512–9518, 2006. View at Publisher · View at Google Scholar · View at Scopus
  19. Y. D. Dong, A. W. Dong, I. Larson et al., “Impurities in commercial phytantriol significantly alter its lyotropic liquid-crystalline phase behavior,” Langmuir, vol. 24, no. 13, pp. 6998–7003, 2008. View at Publisher · View at Google Scholar · View at Scopus
  20. E. Esposito, N. Eblovi, S. Rasi et al., “Lipid-based supramolecular systems for topical application: a preformulatory study.,” The American Association of Pharmaceutical Scientists, vol. 5, no. 4 article E30, 2003. View at Google Scholar · View at Scopus
  21. E. Esposito, R. Cortesi, M. Drechsler et al., “Cubosome dispersions as delivery systems for percutaneous administration of indomethacin,” Pharmaceutical Research, vol. 22, no. 12, pp. 2163–2173, 2005. View at Publisher · View at Google Scholar · View at Scopus
  22. B. Siekmann, H. Bunjes, M. H. J. Koch, and K. Westesen, “Preparation and structural investigations of colloidal dispersions prepared from cubic monoglyceride-water phases,” International Journal of Pharmaceutics, vol. 244, no. 1-2, pp. 33–43, 2002. View at Publisher · View at Google Scholar · View at Scopus
  23. H. Chung, J. Kim, J. Y. Um, I. C. Kwon, and S. Y. Jeong, “Self-assembled “nanocubicle” as a carrier for peroral insulin delivery,” Diabetologia, vol. 45, no. 3, pp. 448–451, 2002. View at Publisher · View at Google Scholar · View at Scopus
  24. M. L. Adams and G. S. Kwon, “Relative aggregation state and hemolytic activity of amphotericin B encapsulated by poly(ethylene oxide)-block-poly(N-hexyl-L-aspartamide)-acyl conjugate micelles: effects of acyl chain length,” Journal of Controlled Release, vol. 87, no. 1–3, pp. 23–32, 2003. View at Publisher · View at Google Scholar · View at Scopus
  25. F. Muller, A. Salonen, and O. Glatter, “Phase behavior of Phytantriol/water bicontinuous cubic Pn3m cubosomes stabilized by Laponite disc-like particles,” Journal of Colloid and Interface Science, vol. 342, no. 2, pp. 392–398, 2010. View at Publisher · View at Google Scholar · View at Scopus
  26. T. Korjamo, A. T. Heikkinen, and J. Mönkkönen, “Analysis of unstirred water layer in in vitro permeability experiments,” Journal of Pharmaceutical Sciences, vol. 98, no. 12, pp. 4469–4479, 2009. View at Publisher · View at Google Scholar · View at Scopus
  27. A. S. Sallam, E. Khalil, H. Ibrahim, and I. Freij, “Formulation of an oral dosage form utilizing the properties of cubic liquid crystalline phases of glyceryl monooleate,” European Journal of Pharmaceutics and Biopharmaceutics, vol. 53, no. 3, pp. 343–352, 2002. View at Publisher · View at Google Scholar · View at Scopus
  28. J. Y. Um, H. Chung, K. S. Kim, I. C. Kwon, and S. Y. Jeong, “In vitro cellular interaction and absorption of dispersed cubic particles,” International Journal of Pharmaceutics, vol. 253, no. 1-2, pp. 71–80, 2003. View at Publisher · View at Google Scholar · View at Scopus
  29. K. Katneni, S. A. Charman, and C. J. H. Porter, “An evaluation of the relative roles of the unstirred water layer and receptor sink in limiting the in-vitro intestinal permeability of drug compounds of varying lipophilicity,” Journal of Pharmacy and Pharmacology, vol. 60, no. 10, pp. 1311–1319, 2008. View at Publisher · View at Google Scholar · View at Scopus
  30. G. Mittal, D. K. Sahana, V. Bhardwaj, and M. N. V. Ravi Kumar, “Estradiol loaded PLGA nanoparticles for oral administration: effect of polymer molecular weight and copolymer composition on release behavior in vitro and in vivo,” Journal of Controlled Release, vol. 119, no. 1, pp. 77–85, 2007. View at Publisher · View at Google Scholar · View at Scopus
  31. M. P. Desai, V. Labhasetwar, G. L. Amidon, and R. J. Levy, “Gastrointestinal uptake of biodegradable microparticles: effect of particle size,” Pharmaceutical Research, vol. 13, no. 12, pp. 1838–1845, 1996. View at Publisher · View at Google Scholar · View at Scopus
  32. M. P. Desai, V. Labhasetwar, E. Walter, R. J. Levy, and G. L. Amidon, “The mechanism of uptake of biodegradable microparticles in Caco-2 cells is size dependent,” Pharmaceutical Research, vol. 14, no. 11, pp. 1568–1573, 1997. View at Publisher · View at Google Scholar · View at Scopus
  33. E. K. Wasan, K. Bartlett, P. Gershkovich et al., “Development and characterization of oral lipid-based Amphotericin B formulations with enhanced drug solubility, stability and antifungal activity in rats infected with Aspergillus fumigatus or Candida albicans,” International Journal of Pharmaceutics, vol. 372, no. 1-2, pp. 76–84, 2009. View at Publisher · View at Google Scholar · View at Scopus
  34. R. H. Müller, S. Schmidt, I. Buttle, A. Akkar, J. Schmitt, and S. Brömer, “SolEmuls-novel technology for the formulation of i.v. emulsions with poorly soluble drugs,” International Journal of Pharmaceutics, vol. 269, no. 2, pp. 293–302, 2004. View at Publisher · View at Google Scholar · View at Scopus